Long-running legal battles culminated in a ruling that preserves public housing benefits and inheritance rights in the territory.
Posts tagged All News
Ranvir’s Portfolio (26-11-2024)
Emami Ltd –
Q2 FY 25 results and concall highlights –
Revenues – 891 cr, up 3 pc
Gross Margins @ 70.7 vs 70.1 pc
EBITDA – 250 cr, up 7 pc ( margins @ 28.1 vs 27.0 pc )
PAT – 213 cr, up 19 pc
Company acquired an additional stake of 48 pc in the ‘Man Company’ to hike it from 50 to 98 pc
Organised channels like Modern trade, E-Comm, Institutional and Quick commerce sales now account for 27 pc of company’s sales ( vs 25 pc in H1 LY )
Have re-launched Kesh King and Fair & Handsome in Q3 – should refresh the brands and boost sales
Domestic sales grew 3 pc (led by 1.5 pc volume growth)
Intl sales grew by 6 pc (ex-Bangladesh, grew by 12 pc)
Brand wise performance –
Cooling oils – Navratna + Dermi Cool grew by 10 pc
Zandu Healthcare range grew by 11 pc
Boroplus range grew by 2 pc
Pain Management range grew by 5 pc
Male grooming (HE + Fair & Handsome brand of products) de-grew by 13 pc
Kesh King range de-grew by 9 pc
7 in 1 Oils de-grew by 3 pc
Kesh King and Male grooming brands ( HE + Fair & Handsome ) have been struggling for growth for quite some time now. Company has engaged BCG ( in Aug ) to revive these brands.BCG will also be working on the Boroplus brand. Expect some benefits to start flowing through wef FY 26
Company is spending disproportionately behind Kesh King Oil and shampoo as they believe this brand can have a great future
Loading of channels for winter months will happen only in Q3
Company strongly believes – as the rural markets bounce back, Emami shall be the biggest beneficiary as they have invested a lot in the rural channels
If the Winters are strong, Boroplus brand should end up doing well ( specially now with so many brand extensions of Boroplus being available in the mkt ). 75 pc of Boroplus sales come from the Anti-Septic cream and the rest come from – body lotion + soap + face wash + talcum powder. 5 yrs back, 90 pc of sales used to come from the anti-septic cream
The ‘Man Company’ is undergoing ownership transition. Should get over by Nov. Expect growth here to pick up wef Q4
Pain management did see some pickup in Oct. Should see handsome numbers in Q3 wrt Pain Management sales
Hair fall category ( company has its brand – Kesh King in this space ) is facing a lot of competition from new start-ups like Traya etc
The Man Company is currently doing sales of 180 cr/yr. Company expects to take it to > 350 cr in next 3-4 yrs. Most of the sales for The Man Company come from E-Comm. Will be launching it in other channels as well
Tax rates for full FY should remain in the 9-10 pc band
Emami Ltd also holds 26 pc stake in Axiom Ayurveda ( maker of Aloe branded fruit juices )
Disc : hold a small tracking position, will add only if key brands turn around, biased, not a buy/sell recommendation, not SEBI registered
Windsor Machines Ltd (26-11-2024)
Hi, is anyone still tracking this company? If so, please share any reasons that have led to a huge run up in stock over the past few days
This pharma stock listed in July has rallied 10% in trade; Check details (26-11-2024)
The stock was listed on July 10, 2024, and made a stellar debut on Indian bourses with the shares getting listed at Rs 1,325.05 on the BSE, a 31.45 per cent premium over its issue price
AstraZeneca Pharma shares up on CDSCO nod for cancer drug Lynparza (26-11-2024)
This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatment for adult patients with advanced or recurrent endometrial cancer, said AstraZeneca Pharma
Suraksha Diagnostic aims to raise Rs 846 cr through IPO, sets price band (26-11-2024)
Integrated diagnostic chain Suraksha Diagnostic Ltd on Tuesday said it has fixed a price band of Rs 420 to Rs 441 apiece for its Rs 846-crore initial public offering (IPO).
The initial share-sale will open for public subscription on November 29 and conclude on December 3 and the bidding for anchor investors will open for a day on November 28, the company announced.
The Kolkata-headquartered company’s IPO consists of an Offer-for-Sale (OFS) of 19,189,330 equity shares worth Rs 846.25 crore, at the upper end of the price band, by promoters and investor shareholders, with no fresh issue component.
Under the OFS, promoters — Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma and investors — OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal and Santosh Kumar Kejriwal will offload shares.
Since the issue is completely an OFS, the company will not receive any proceeds and all the funds will go to the selling shareholders.
Explaining the reason for going public, the company said it is
Share price of Adani Power as Sensex drops 171.75 points (26-11-2024)
A total of 1,636,404 shares changed hands on the counter till 02:12PM (IST)
How small telecom tariff hikes are driving big ARPU gains? Gaurav Malhotra explains (26-11-2024)
So, we will have to wait for that before we can see how much of the debt Vodafone is able to raise but their intention is to raise around 25,000 crores.